emerg
infecti
diseas
eid
alway
one
major
threat
public
health
although
implement
mandatori
test
classic
transfusiontransmit
infectioushuman
immunodefici
viru
hepat
b
viru
hepat
c
viru
syphilisha
reduc
transfus
risk
pathogen
potenti
threat
variou
eid
agent
constantli
evolv
variant
blood
safeti
china
fulli
understood
review
present
repres
eid
agent
autochthon
epidem
nation
region
china
epidemiolog
statu
distribut
eid
agent
among
donor
andor
healthi
popul
summar
potenti
risk
eid
agent
blood
safeti
discuss
review
also
explor
strategi
strengthen
hemovigil
system
studi
evalu
impact
eid
agent
blood
safeti
emerg
infecti
diseas
eid
agent
consid
major
threat
transfus
safeti
notori
eid
agent
sabotag
blood
safeti
human
immunodefici
viru
hiv
rais
global
concern
eid
trigger
organ
activ
systemat
prevent
eid
agent
threaten
transfus
safeti
nowaday
blood
donat
screen
variou
infecti
agent
develop
countri
region
eid
agent
well
studi
unit
state
blood
suppli
routin
screen
human
tlymphocyt
viru
htlv
west
nile
viru
wnv
trypanosoma
cruzi
babesia
spp
systemat
scrutin
evalu
valu
donor
screen
zika
viru
recent
emerg
eid
threat
china
howev
mani
eid
agent
rare
investig
among
blood
donor
evid
impact
blood
safeti
absent
american
associ
blood
bank
publish
catalog
pathogen
relev
blood
transfus
medicin
review
j
u
r
n
l
h
e
p
g
e
w
w
w
r
e
v
e
w
c
safeti
eid
agent
list
confirm
suspect
associ
transfus
transmiss
infect
tti
threat
eid
agent
blood
safeti
vari
due
differ
spread
pattern
transmiss
rout
epidemiolog
characterist
endem
statu
therefor
need
specif
evalu
countri
area
china
blood
donor
routin
test
pathogen
hepat
b
viru
hbv
hepat
c
viru
hcv
syphili
broad
implement
nucleic
acid
test
nat
improv
perform
enzym
immunoassay
assay
rigor
polici
donor
recruit
test
transfus
risk
convent
tti
larg
reduc
china
howev
mani
divers
distribut
eid
agent
still
pose
potenti
threat
blood
safeti
yet
risk
never
fulli
evalu
nevertheless
china
wit
recurr
outbreak
highli
virul
eid
includ
sever
acut
respiratori
syndrom
sar
highli
pathogen
avian
influenza
streptococcu
sui
zoonot
bacterium
mostli
carri
pig
pork
product
caus
syndrom
streptococc
toxic
shock
sepsi
mening
exampl
outbreak
human
streptococcu
sui
infect
china
report
sichuan
provinc
result
laboratori
confirm
case
death
midjuli
end
august
eid
agent
asymptomat
distribut
among
chines
gener
popul
malaria
hepat
e
viru
dengu
viru
may
emerg
greater
threat
chines
blood
safeti
requir
intervent
review
highlight
repres
autochthon
eid
agent
nationwid
region
epidem
epidemiolog
eid
agent
investig
among
blood
donor
andor
gener
popul
review
geograph
distribut
eid
agent
region
epidem
summar
preval
eid
agent
among
chines
donor
summar
human
parvoviru
small
nonenvelop
singlestrand
dna
viru
caus
variou
clinic
manifest
chronic
anemia
aplast
crise
arthropathi
varieti
syndrom
among
immunecompromis
immunosuppress
patient
confirm
one
tti
transmit
blood
blood
product
us
food
drug
administr
fda
european
pharmacopeia
propos
limit
geqml
pooledplasma
order
reduc
potenti
risk
transmiss
limit
data
preval
among
blood
donor
gener
popul
china
accord
sever
report
estim
preval
rate
could
high
gener
chines
popul
hiv
coinfect
individu
tibetan
area
dna
posit
rate
among
gener
popul
among
chines
blood
donor
dna
preval
rate
much
lower
gener
popul
studi
also
report
differ
geograph
locat
demonstr
differ
preval
rate
dna
sequenc
xinjiang
provinc
show
differ
genet
lineag
place
china
anoth
studi
dna
detect
plasma
pool
chines
blood
product
manufactur
intraven
immunoglobulin
ivig
factor
viii
fibrinogen
prothrombin
complex
concentr
level
vari
geqml
geqml
viral
load
one
donat
sampl
geqml
significantli
higher
threshold
recommend
us
fda
european
pharmacopeia
geqml
investig
necessari
determin
whether
nat
screen
implement
routin
chines
blood
center
current
contamin
plasma
product
seriou
concern
malaria
malaria
caus
infect
parasit
plasmodia
spp
current
distribut
cover
tropic
larg
part
subtrop
infect
plasmodia
spp
often
resembl
common
viral
infect
may
lead
delay
diagnosi
malaria
consid
transfus
risk
sinc
asymptomat
immigr
resid
travel
visit
endem
area
might
import
malaria
nonendem
area
therefor
us
fda
initi
donor
deferr
polici
temporarili
defer
donor
travel
endem
area
result
us
donor
defer
reason
malaria
highli
endem
china
estim
million
case
per
year
chines
govern
began
tremend
effort
elimin
malaria
nation
malaria
control
program
launch
main
speci
caus
malaria
china
p
vivax
found
mani
region
howev
speci
plasmodia
also
report
although
malaria
well
control
last
decad
sporad
outbreak
frequent
report
malaria
remain
report
infecti
diseas
china
sever
case
malaria
transmiss
transfus
recent
report
tabl
meanwhil
dna
p
knowlesi
also
found
pool
plasma
manufactur
guizhou
howev
current
chines
blood
center
polici
defer
donor
travel
malaria
endem
area
malaria
infect
countri
epidem
season
actual
preval
malaria
residu
risk
among
voluntari
blood
donor
unknown
studi
malaria
infect
blood
donor
china
survey
risk
infect
demograph
characterist
plasmodium
infect
donor
crucial
better
understand
transfus
risk
malaria
china
hepat
e
viru
hev
enter
transmit
positivesens
singlestrand
nonenvelop
rna
icosahedr
viru
usual
caus
acut
selflimit
infect
hev
worldwid
distribut
substanti
morbid
mortal
develop
countri
mani
case
hev
transmiss
blood
transfus
document
world
routin
screen
donor
hev
rna
suggest
studi
china
antihev
seropreval
gener
popul
increas
age
per
year
approxim
individu
igm
posit
indic
acut
infect
asymptomat
viremia
earli
due
frequent
occurr
illeg
blood
donat
central
china
antihev
igg
preval
spike
antihev
igm
preval
among
illeg
blood
donor
recent
studi
use
test
result
routin
donat
collect
urban
blood
center
investig
report
preval
antihev
igg
antihev
igm
hev
rna
among
donat
addit
found
preval
rate
vari
blood
center
locat
compar
studi
sampl
qualifi
blood
donor
donor
defer
due
elev
alanin
aminotransferas
alt
examin
preval
rate
antihev
igm
antihev
igg
altelev
donor
respect
significantli
higher
qualifi
donor
respect
meanwhil
preval
hev
antigen
among
altelev
donor
also
higher
among
qualifi
donor
statist
signific
level
data
suggest
routin
prescreen
postdon
alt
test
reduc
elimin
potenti
risk
hev
infect
otherwis
qualifi
donat
china
dengu
virus
denv
denv
caus
dengu
fever
dengu
hemorrhag
fever
dhf
dengu
shock
syndrom
denv
lifethreaten
mosquitoborn
diseas
global
spread
denv
shown
capabl
transmiss
transfus
transfus
red
blood
cell
test
denv
seroneg
rna
posit
high
viral
load
copiesml
lead
denv
infect
transfus
recipi
sever
countri
region
high
preval
denv
investig
denv
among
blood
donor
recipi
evalu
impact
blood
safeti
well
develop
proper
donor
enrol
strategi
reduc
transfusiontransmiss
risk
china
earli
outbreak
dhf
report
mostli
guangdong
guangxi
yunnan
hainan
fujian
zhejiang
provinc
locat
southeast
coastal
region
border
area
next
southeast
asia
document
dhf
case
guangdong
provinc
one
develop
provinc
locat
south
coastal
area
sinc
dengu
fever
first
reemerg
guangdong
provinc
epidem
denv
spread
chines
provinc
epidem
statu
dhf
gradual
chang
sporad
import
autochthon
endem
case
larg
dhf
outbreak
juli
novemb
foshan
citi
guangdong
provinc
suspect
febril
case
among
denv
infect
confirm
laboratori
test
rna
posit
igm
posit
follow
year
third
histor
largest
dhf
outbreak
spread
throughout
guangdong
provinc
citi
report
case
febril
case
denv
infect
confirm
result
death
partli
respons
outbreak
chines
center
diseas
control
prevent
cdc
amend
guidelin
dhf
prevent
control
strengthen
implement
mosquito
control
dhf
case
guangdong
provinc
drop
sharpli
case
end
septemb
reflect
effect
denv
control
measur
area
denv
sentinel
monitor
serosurveil
oper
dhf
epidem
region
china
sinc
denv
seropreval
rate
vari
igg
igm
denv
endem
area
guangdong
guangxi
yunnan
hainan
fujian
provinc
pilot
studi
denv
serolog
viremia
among
asymptomat
donor
guangzhou
citi
guangdong
provinc
septemb
octob
found
denv
igm
preval
rate
n
studi
also
identifi
one
denv
rna
posit
donor
viral
load
copiesml
anoth
postoutbreak
serolog
investig
among
healthi
popul
foshan
citi
next
guangzhou
citi
found
significantli
higher
denv
seropreval
rate
town
experienc
dhf
outbreak
igg
rate
n
compar
town
without
autochthon
case
igg
rate
blood
product
denv
rna
viremia
potenti
lead
transfusiontransmit
infect
howev
date
publish
studi
denv
transmiss
via
transfus
china
human
brucellosi
caus
brucella
spp
one
sever
zoonot
diseas
worldwid
transfusiontransmit
brucellosi
case
report
sinc
brucella
spp
consid
potenti
risk
blood
safeti
human
brucellosi
one
lead
threat
public
health
farm
area
livestock
china
brucellosi
case
china
found
north
china
concentr
inner
mongolia
shaanxi
heilongjiang
jilin
hebei
provinc
total
brucellosi
case
confirm
area
addit
rapidli
increas
trend
observ
brucellosi
incid
case
per
peopl
clinic
case
per
peopl
epidemiolog
investig
inner
mongolia
report
incid
rate
high
among
peopl
close
contact
livestock
china
brucella
surveil
focus
risk
factor
infect
preval
dairi
cattl
local
anim
goal
provid
inform
brucellosi
prevent
control
dna
preval
rate
brucella
raw
whole
milk
sampl
found
provinc
lowrisk
popul
urban
area
increas
risk
brucellosi
contamin
milk
raw
meat
limit
data
show
seropreval
rate
brucella
among
healthi
human
popul
endem
area
recent
brucella
spp
investig
base
enzym
immunoassay
test
among
blood
donor
endem
area
kashi
xinjiang
provinc
show
reactiv
rate
sampl
confirm
western
blot
wb
test
brucella
dna
preval
rate
although
infect
case
transmit
transfus
report
exist
brucella
dna
donor
plasma
sampl
indic
potenti
risk
transfusiontransmit
brucellosi
endem
area
warrant
futur
investig
first
retroviru
discov
human
htlv
one
import
tti
may
lead
variou
human
diseas
adult
tcell
leukemialymphoma
myelopathytrop
spastic
paraparesi
opportunist
infect
inflammatori
disord
implement
mandatori
test
donor
effect
sinc
mani
countri
reduc
risk
transfus
transmiss
china
serosurveil
htlv
among
gener
popul
start
earli
studi
beij
provinc
found
posit
rate
samplesal
connect
endem
countri
japan
nationwid
investig
report
preval
htlv
among
blood
donor
n
n
respect
metaanalysi
studi
among
donor
provinc
region
found
pool
estim
preval
fujian
guangdong
ci
ci
respect
isol
belong
transcontinent
subgroup
wherea
case
infect
found
among
donor
provinc
region
data
studi
indic
htlv
preval
low
china
infect
expand
concentr
coastal
region
fujian
guangdong
neighbor
provinc
seropreval
remain
low
rang
shanghai
jiangxi
although
transfusiontransmit
htlv
infect
report
surveil
htlv
among
blood
donor
evalu
impact
blood
safeti
continu
studi
china
sever
fever
thrombocytopenia
syndrom
viru
sftsv
novel
tickborn
bunyaviru
first
identifi
china
etiolog
agent
sever
fever
thrombocytopenia
syndrom
sft
initi
fatal
rate
sftsv
concentr
mountain
rural
area
central
eastern
china
epidem
season
sft
mainli
spring
autumn
peak
may
juli
farmer
high
risk
sft
due
exposur
tick
molecular
characterist
epidemiolog
distribut
risk
factor
clinic
symptom
well
summar
sever
review
end
sftsv
spread
provinc
provinc
grow
incid
decreas
fatal
rate
increas
epidem
sft
report
annual
incid
estim
case
per
popul
autochthon
endem
area
meanwhil
increas
number
sft
case
report
japan
south
korea
migratori
bird
suspect
play
import
role
promot
spread
sftsv
east
asia
although
record
transfusiontransmit
sft
case
present
sftsv
potenti
becom
transfusiontransmit
infecti
agent
due
sever
consider
nosocomi
transmiss
caus
direct
exposur
sft
patient
blood
demonstr
sftsv
bloodborn
pathogen
incub
period
infect
onset
diseas
one
week
averag
case
thirti
day
virem
asymptomat
blood
donor
within
incub
period
may
therefor
potenti
transmit
sftsv
recipi
lead
sft
studi
launch
nation
heart
lung
blood
institut
john
hopkin
univers
chines
institut
blood
transfus
chines
blood
center
one
locat
endem
nonendem
region
antibodi
screen
followup
sftsv
rna
detect
perform
blood
donor
plasma
sampl
collect
april
octob
seropreval
rate
endem
area
xinyang
nonendem
region
mianyang
luoyang
respect
signific
differ
observ
p
n
among
donor
screen
minipool
sftsv
rna
test
suspect
virem
sampl
detect
viral
load
less
plaqueform
unit
pfu
ml
region
sftsv
among
healthi
individu
report
seropreval
rate
vari
epidem
area
find
asymptomat
virem
case
continu
investig
need
evalu
whether
sftsv
present
risk
transfus
recipi
china
leishmania
infect
respons
cutan
viscer
leishmaniasi
kalaazar
leishmania
spp
usual
transmit
peopl
phlebotomin
sandfli
infect
individu
may
harbor
persist
infect
year
recoveri
transmiss
leishmania
infect
via
blood
demonstr
anim
well
human
be
leishmania
human
red
blood
cell
rbc
surviv
long
day
blood
bank
storag
condit
report
caus
cutan
viscer
leishmaniasi
infant
immunocompromis
patient
asymptomat
infect
usual
found
healthi
blood
donor
endem
area
us
militari
blood
bank
enforc
perman
deferr
individu
histori
leishmaniasi
exist
regul
standard
leishmania
test
civilian
donor
screen
document
kalaazar
case
china
mainli
rural
area
north
effort
nation
control
program
kalaazar
almost
elimin
current
case
kalaazar
report
year
mainli
xinjiang
provinc
provinc
western
china
recent
retrospect
studi
viscer
leishmaniasi
chines
cdc
report
increas
number
viscer
leishmaniasi
case
endem
area
indic
prevent
control
strategi
must
taken
restrain
increas
incid
spread
leishmaniasi
otherwis
frequent
popul
migrat
tourism
rapidli
grow
public
transport
may
lead
spread
infect
push
list
transfusiontransmit
infecti
diseas
china
date
still
survey
studi
infect
among
donor
document
transfusiontransmit
case
leishmania
infect
china
q
fever
zoonosi
due
coxiella
burnetii
infect
c
burnetii
usual
caus
asymptomat
clinic
manifest
flulik
diseas
atyp
pneumonia
human
howev
acut
fatal
chronic
infect
report
larg
outbreak
q
fever
netherland
hogema
et
al
initi
surveil
c
burnetii
dna
antibodi
local
blood
donat
found
c
burnetii
dna
posit
rate
igg
seroposit
rate
furthermor
seroconvers
detect
donor
incid
rate
per
year
outbreak
great
outbreak
q
fever
slot
et
al
start
investig
chronic
infect
donor
pose
threat
blood
safeti
netherland
serolog
result
serum
sampl
collect
affect
area
august
januari
show
chronic
c
burnetii
infect
absent
epidem
blood
donor
led
donor
reentri
polici
alreadi
initi
elsewher
europ
china
c
burnetii
infect
observ
tibet
yunnan
xinjiang
inner
mongolia
c
burnetii
dna
posit
rate
tick
human
western
china
q
fever
mainli
airborn
diseas
individu
exposur
livestock
bear
higher
risk
epidemiolog
studi
show
rural
farmer
antibodi
c
burnetii
although
blood
donor
screen
c
burnetii
initi
china
dna
c
burnetii
found
pool
plasma
manufactur
guizhou
crosssect
studi
seropreval
viremia
statu
c
burnetii
among
blood
donor
especi
nomad
herd
livestock
region
would
provid
comprehens
assess
impact
blood
safeti
china
due
biolog
geograph
divers
china
alway
high
risk
variou
eid
agent
popul
countri
dramat
rampup
number
blood
donat
report
recent
million
donat
collect
donat
index
donat
per
peopl
howev
monitor
classic
tti
hiv
hbv
hcv
syphili
well
eid
agent
implement
chines
cdc
mostli
base
sentinel
investig
clinic
case
report
system
monitor
system
demonstr
effect
establish
proper
guidelin
diseas
prevent
control
base
epidemiolog
analysi
transmiss
rout
infect
risk
factor
fatal
rate
clinic
symptom
document
case
period
summar
analyz
help
diagnosi
therapi
pathogen
well
develop
improv
laboratori
diagnost
assay
effort
toward
diseas
control
benefit
system
face
sever
outbreak
eid
epidem
sar
sftsv
denv
region
spread
infect
import
aspect
consid
evalu
transfus
risk
eid
agent
among
eid
agent
list
proven
result
patholog
autochthon
epidem
china
hev
plasmodium
spp
nationwid
distribut
three
insectborn
eid
agent
denv
sftsv
leishmania
spp
zoonos
brucella
spp
c
burnetii
display
signific
geograph
divers
due
pattern
transmiss
htlv
cluster
one
coastal
region
region
distribut
eid
agent
shown
fig
surprisingli
region
distribut
insectborn
pathogen
match
diseas
vector
mosquito
sandfli
tick
denv
welldescrib
mosquitoborn
viru
global
distribut
tropic
subtrop
area
locat
recent
outbreak
dhf
infect
sftsv
novel
tickborn
bunyaviru
identifi
sft
patient
rural
mountain
area
central
eastern
china
mainli
higher
risk
tick
exposur
similar
way
infect
zoonot
diseas
qfever
brucellosi
found
rural
livestock
farm
area
northern
western
china
compil
distribut
report
clinic
case
preval
eid
agent
donor
andor
gener
popul
provid
estim
frequenc
eid
agent
among
chines
blood
donor
popul
see
fig
hev
estim
nation
distribut
among
donor
gener
popul
china
base
previou
crosssect
studi
spread
brucella
spp
depend
transmiss
rout
contamin
milk
raw
meat
produc
endem
region
consid
current
dna
preval
rate
brucella
spp
among
blood
donor
endem
region
potenti
high
frequenc
gener
donor
popul
eid
matter
concern
shadow
recent
global
outbreak
fast
expand
trend
dhf
denv
also
highlight
potenti
risk
endem
area
china
region
concentr
eid
agent
qfever
leishmania
spp
sftsv
estim
moder
low
frequenc
among
blood
donor
popul
howev
ongo
surveil
eid
agent
donor
prudent
order
provid
sound
evid
regard
impact
blood
safeti
china
order
evalu
impact
eid
blood
safeti
practic
feasibl
approach
monitor
exist
eid
agent
among
asymptomat
blood
donor
obtain
direct
evid
transfusiontransmit
case
confirm
molecular
analysi
firstli
surveil
among
blood
donor
seromark
nucleic
acid
pathogen
provid
data
estim
transfus
risk
among
eid
discuss
review
htlv
continu
investig
blood
center
sinc
investig
case
report
hev
plasmodium
spp
among
blood
donor
systemat
continu
investig
eid
data
sftsv
denv
brucella
spp
china
limit
one
document
donor
surveil
studi
avail
agent
c
burnetii
q
fever
leishmania
spp
investig
addit
wellorgan
appropri
design
donorrecipi
linkag
studi
may
directli
confirm
transmiss
transfus
facilit
evalu
posttransfus
outcom
yield
convinc
evid
support
strategi
screen
donor
eid
agent
although
china
perform
linkag
studi
brazil
examin
donorrecipi
linkag
dengu
viru
use
larg
nation
repres
databas
studi
may
serv
exampl
follow
order
evalu
transfus
risk
eid
china
collabor
effort
global
surveil
program
may
prove
use
mitig
transfus
risk
eid
although
eid
agent
china
histor
import
agent
sar
sftsv
origin
china
expand
adjac
countri
also
nonendem
eid
agent
west
nile
viru
wnv
chikungunya
viru
variant
creutzfeldtjacob
diseas
vcjd
zika
viru
zikv
immedi
address
due
worldwid
distribut
sever
clinic
outcom
recent
transfusiontransmit
zikv
document
sever
case
zikv
infect
among
travel
epidem
area
report
china
current
immigr
author
recommend
oral
fig
distribut
major
region
eid
agent
china
declar
infect
entryexit
inspect
quarantin
symptomat
travel
zikv
epidem
area
upon
entri
china
travel
countri
epidem
vcjd
defer
donat
health
questionnair
chines
blood
center
howev
whether
wnv
chikungunya
viru
zikv
also
ad
deferr
list
remain
matter
controversi
need
evid
investig
pathogen
reduct
blood
product
altern
defens
eid
agent
sever
studi
describ
effect
inactiv
eid
agent
denv
wnv
current
pathogen
reduct
technolog
use
china
methylen
bluephotochem
technolog
appli
plasma
product
technolog
mandatori
perform
blood
center
effort
made
evalu
whether
pathogen
reduct
use
safeguard
blood
suppli
china
costeffect
screen
strategi
key
factor
consid
current
lack
costeffect
studi
exist
screen
strategi
classic
tti
china
studi
need
enhanc
develop
improv
addit
eid
screen
strategi
blood
donat
conclus
threat
blood
safeti
pose
eid
agent
china
requir
evalu
support
substanti
evid
studi
china
implement
effect
blood
screen
strategi
eid
agent
reduc
transfus
risk
patient
